#FDA approvals Dec. 2022: AbbVie’s #Vraylar, Nov

#FDA approvals Dec. 2022: AbbVie’s #Vraylar, Novo Nordisk’s #Wegovy, plus #Briumvi, #Sunlenca, Genentech’s… https://t.co/TLqdBSOmRx

I take #humira. When I had my #miscarriage they se

I take #humira. When I had my #miscarriage they sent me some forms to fill out regarding my meds and when I had… https://t.co/VglFscsCa2

Taking this one group “HS Awareness” as an example there were troubling signs; a list follows

*Founders publish in… https://t.co/d1ZHLCMmSk

@Healthcare_ABC expert Brian Biehn is discussing the latest developments in the #biosimilars market, including: the… https://t.co/Q0JlhZln39

@dwancherry Hahahaha as a crohns patient I’ve talked about pooping with parents since I was 20 haha. And the poop jokes never ended since

@Crohns_ryota 私も最近ドーナツ欲やばいです！！！！！
最近、ドーナツのおっきいテイクアウト箱持ってる人を恨めしそうに見てしまいました笑

We welcome you and appreciate your participation at the 16th European Biosimilars Congress, which is going to be he… https://t.co/sInWkuTJgE

@Crohns_ryota クローン病あるあるですね！（笑）
村人A「クローンってひつじとかうしの、、、？」
勇者「いえ、クローンって人が見付けた病気です！」
何度経験したことか（笑）

The Chief Strategy Officer of Alvotech, Ming Li, joined Karen Jagoda on the Empowered Patient Podcast to speak abou… https://t.co/LfHvGaaqPR